{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T13:40:35Z","timestamp":1791294035112,"version":"4.1.0"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuroscience Letters"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.neulet.2016.06.045","type":"journal-article","created":{"date-parts":[[2016,6,24]],"date-time":"2016-06-24T05:21:32Z","timestamp":1466745692000},"page":"24-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"special_numbering":"C","title":["Understanding the molecular mechanisms underlying mood stabilizer treatments in bipolar disorder: Potential involvement of epigenetics"],"prefix":"10.1016","volume":"669","author":[{"given":"Claudia","family":"Pisanu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni Merkouri","family":"Papadima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Del Zompo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Squassina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neulet.2016.06.045_bib0005","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0165-0327(01)00377-9","article-title":"Mortality of patients with mood disorders: follow-up over 34\u201338 years","volume":"68","author":"Angst","year":"2002","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neulet.2016.06.045_bib0010","doi-asserted-by":"crossref","first-page":"491","DOI":"10.2165\/00023210-200317070-00003","article-title":"Suicidal behaviour in bipolar disorder: risk and prevention","volume":"17","author":"Tondo","year":"2003","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neulet.2016.06.045_bib0015","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1001\/archpsyc.64.5.543","article-title":"Lifetime and 12-month prevalence of bipolar spectrum disorder in the National Comorbidity Survey replication","volume":"64","author":"Merikangas","year":"2007","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neulet.2016.06.045_bib0020","unstructured":"Work Group on Bipolar Disorder Practice guidelines for the treatment of patients with Bipolar Disorder, second ed., 2010."},{"key":"10.1016\/j.neulet.2016.06.045_bib0025","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1176\/appi.ajp.161.1.3","article-title":"What is a mood stabilizer? An evidence-based response","volume":"161","author":"Bauer","year":"2004","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.neulet.2016.06.045_bib0030","doi-asserted-by":"crossref","first-page":"349","DOI":"10.5694\/j.1326-5377.1949.tb36912.x","article-title":"Lithium salts in the treatment of psychotic excitement","volume":"2","author":"Cade","year":"1949","journal-title":"Med. J. Aust."},{"issue":"Suppl. 2","key":"10.1016\/j.neulet.2016.06.045_bib0035","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1399-5618.2009.00712.x","article-title":"Maintenance treatment in bipolar disorder: a reassessment of lithium as the first choice","volume":"11","author":"Coryell","year":"2009","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neulet.2016.06.045_bib0040","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1001\/archpsyc.57.2.187","article-title":"Does lithium treatment still work? Evidence of stable responses over three decades","volume":"57","author":"Baldessarini","year":"2000","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.neulet.2016.06.045_bib0045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.jad.2007.03.003","article-title":"Prophylactic treatment response in bipolar disorder: results of a naturalistic observation study","volume":"104","author":"Garnham","year":"2007","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neulet.2016.06.045_bib0050","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1034\/j.1399-5618.2001.030203.x","article-title":"The prophylactic effect of long-term lithium administration in bipolar patients entering treatment in the 1970 and 1980","volume":"3","author":"Rybakowski","year":"2001","journal-title":"Bipolar Disord."},{"key":"10.1016\/j.neulet.2016.06.045_bib0055","doi-asserted-by":"crossref","first-page":"397","DOI":"10.2165\/00023210-200923050-00004","article-title":"Lithium: updated human knowledge using an evidence-based approach: part III: clinical safety","volume":"23","author":"Grandjean","year":"2009","journal-title":"CNS Drugs"},{"key":"10.1016\/j.neulet.2016.06.045_bib0060","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1192\/S000712500029243X","article-title":"The challenge of predicting response to stabilising lithium treatment. The importance of patient selection","author":"Grof","year":"1993","journal-title":"Br. J. Psychiatry Suppl."},{"key":"10.1016\/j.neulet.2016.06.045_bib0065","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/mp.2015.4","article-title":"Lithium in the treatment of bipolar disorder: pharmacology and pharmacogenetics","volume":"20","author":"Alda","year":"2015","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neulet.2016.06.045_bib0070","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(16)00143-4","article-title":"Genetic variants associated with response to lithium treatment in bipolar disorder: a genome-wide association study","volume":"387","author":"Hou","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.neulet.2016.06.045_bib0075","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/nbt.1685","article-title":"Epigenetic modifications and human disease","volume":"28","author":"Portela","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.neulet.2016.06.045_bib0080","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/cr.2011.22","article-title":"Regulation of chromatin by histone modifications","volume":"21","author":"Bannister","year":"2011","journal-title":"Cell Res."},{"key":"10.1016\/j.neulet.2016.06.045_bib0085","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1016\/j.tips.2014.05.004","article-title":"Epigenetic mechanisms of importance for drug treatment","volume":"35","author":"Ivanov","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neulet.2016.06.045_bib0090","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.pneurobio.2015.05.002","article-title":"The epigenetics of aging and neurodegeneration","volume":"131","author":"Lardenoije","year":"2015","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neulet.2016.06.045_bib0095","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.tibs.2005.12.008","article-title":"Genomic DNA methylation: the mark and its mediators","volume":"31","author":"Klose","year":"2006","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.neulet.2016.06.045_bib0100","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.cell.2009.06.049","article-title":"Genome-wide mapping of HATs and HDACs reveals distinct functions in active and inactive genes","volume":"138","author":"Wang","year":"2009","journal-title":"Cell"},{"key":"10.1016\/j.neulet.2016.06.045_bib0105","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"10.1016\/j.neulet.2016.06.045_bib0110","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/nrg3074","article-title":"Non-coding RNAs in human disease","volume":"12","author":"Esteller","year":"2011","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.neulet.2016.06.045_bib0115","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuroscience.2012.11.030","article-title":"Significance of epigenetics for understanding brain development, brain evolution and behaviour","volume":"264","author":"Keverne","year":"2014","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2016.06.045_bib0120","doi-asserted-by":"crossref","first-page":"94","DOI":"10.9758\/cpn.2014.12.2.94","article-title":"Potential molecular and cellular mechanism of psychotropic drugs","volume":"12","author":"Seo","year":"2014","journal-title":"Clin. Psychopharmacol. Neurosci."},{"key":"10.1016\/j.neulet.2016.06.045_bib0125","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1093\/hmg\/ddl253","article-title":"Hypomethylation of MB-COMT promoter is a major risk factor for schizophrenia and bipolar disorder","volume":"15","author":"Abdolmaleky","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.neulet.2016.06.045_bib0130","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4161\/epi.2.1.4063","article-title":"Reviewing the role of DNA (cytosine-5) methyltransferase overexpression in the cortical GABAergic dysfunction associated with psychosis vulnerability","volume":"2","author":"Costa","year":"2007","journal-title":"Epigenetics"},{"key":"10.1016\/j.neulet.2016.06.045_bib0135","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.schres.2011.04.007","article-title":"Epigenetic dysregulation of HTR2A in the brain of patients with schizophrenia and bipolar disorder","volume":"129","author":"Abdolmaleky","year":"2011","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neulet.2016.06.045_bib0140","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.jad.2011.03.018","article-title":"Increased DNA methylation status of the serotonin receptor 5HTR1A gene promoter in schizophrenia and bipolar disorder","volume":"132","author":"Carrard","year":"2011","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neulet.2016.06.045_bib0145","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1038\/npp.2012.10","article-title":"Selective DNA methylation of BDNF promoter in bipolar disorder: differences among patients with BDI and BDII","volume":"37","author":"D'Addario","year":"2012","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2016.06.045_bib0150","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/j.jpsychires.2011.04.008","article-title":"State-dependent changes in the expression of DNA methyltransferases in mood disorder patients","volume":"45","author":"Higuchi","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neulet.2016.06.045_bib0155","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/mp.2011.174","article-title":"Enrichment of cis-regulatory gene expression SNPs and methylation quantitative trait loci among bipolar disorder susceptibility variants","volume":"18","author":"Gamazon","year":"2013","journal-title":"Mol. Psychiatry"},{"key":"10.1016\/j.neulet.2016.06.045_bib0160","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1017\/S1461145712000363","article-title":"H3K4 tri-methylation in synapsin genes leads to different expression patterns in bipolar disorder and major depression","volume":"16","author":"Cruceanu","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neulet.2016.06.045_bib0165","doi-asserted-by":"crossref","first-page":"e32680","DOI":"10.1371\/journal.pone.0032680","article-title":"Synapsin II is involved in the molecular pathway of lithium treatment in bipolar disorder","volume":"7","author":"Cruceanu","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2016.06.045_bib0170","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1111\/j.1471-4159.2005.03040.x","article-title":"Histone deacetylase inhibitors decrease reelin promoter methylation in vitro","volume":"93","author":"Mitchell","year":"2005","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neulet.2016.06.045_bib0175","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1016\/j.jpsychires.2008.12.006","article-title":"Histone deacetylase inhibitors and candidate gene expression: an in vivo and in vitro approach to studying chromatin remodeling in a clinical population","volume":"43","author":"Gavin","year":"2009","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neulet.2016.06.045_bib0180","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.schres.2006.07.015","article-title":"Valproic acid and chromatin remodeling in schizophrenia and bipolar disorder: preliminary results from a clinical population","volume":"88","author":"Sharma","year":"2006","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neulet.2016.06.045_bib0185","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2217\/epi.15.98","article-title":"DNA methylation signatures of mood stabilizers and antipsychotics in bipolar disorder","volume":"8","author":"Houtepen","year":"2016","journal-title":"Epigenomics"},{"key":"10.1016\/j.neulet.2016.06.045_bib0190","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1007\/s00210-013-0853-4","article-title":"Valproic acid: an anticonvulsant drug with potent antinociceptive and anti-inflammatory properties","volume":"386","author":"Ximenes","year":"2013","journal-title":"Naunyn Schmiedeberg's Arch. Pharmacol."},{"key":"10.1016\/j.neulet.2016.06.045_bib0195","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1017\/S1461145713001569","article-title":"Decreased global methylation in patients with bipolar disorder who respond to lithium","volume":"17","author":"Huzayyin","year":"2014","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neulet.2016.06.045_bib0200","doi-asserted-by":"crossref","first-page":"942","DOI":"10.4088\/JCP.v63n1013","article-title":"Is response to prophylactic lithium a familial trait?","volume":"63","author":"Grof","year":"2002","journal-title":"J. Clin. Psychiatry"},{"key":"10.1016\/j.neulet.2016.06.045_bib0205","doi-asserted-by":"crossref","first-page":"e65636","DOI":"10.1371\/journal.pone.0065636","article-title":"Assessment of response to lithium maintenance treatment in bipolar disorder: a consortium on lithium genetics (ConLiGen) report","volume":"8","author":"Manchia","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2016.06.045_bib0210","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jpsychires.2013.11.011","article-title":"Oxidative stress in early stage bipolar disorder and the association with response to lithium","volume":"50","author":"de Sousa","year":"2014","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neulet.2016.06.045_bib0215","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.schres.2007.01.030","article-title":"DNA fragmentation is increased in non-GABAergic neurons in bipolar disorder but not in schizophrenia","volume":"93","author":"Buttner","year":"2007","journal-title":"Schizophr. Res."},{"key":"10.1016\/j.neulet.2016.06.045_bib0220","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1093\/carcin\/16.5.1253","article-title":"DNA adduct 8-hydroxyl-2\u2032-deoxyguanosine (8-hydroxyguanine) affects function of human DNA methyltransferase","volume":"16","author":"Turk","year":"1995","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.neulet.2016.06.045_bib0225","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1016\/j.freeradbiomed.2007.06.027","article-title":"An epigenetic perspective on the free radical theory of development","volume":"43","author":"Hitchler","year":"2007","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.neulet.2016.06.045_bib0230","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.neuroscience.2007.10.041","article-title":"The effect of mood stabilizer lithium on expression and activity of glutathione s-transferase isoenzymes","volume":"151","author":"Shao","year":"2008","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2016.06.045_bib0235","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ygeno.2009.12.001","article-title":"EBV transformation and cell culturing destabilizes DNA methylation in human lymphoblastoid cell lines","volume":"95","author":"Grafodatskaya","year":"2010","journal-title":"Genomics"},{"key":"10.1016\/j.neulet.2016.06.045_bib0240","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1093\/ije\/dyv168","article-title":"Lymphoblastoid cell lines reveal associations of adult DNA methylation with childhood and current adversity that are distinct from whole blood associations","volume":"44","author":"Suderman","year":"2015","journal-title":"Int. J. Epidemiol."},{"key":"10.1016\/j.neulet.2016.06.045_bib0245","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1159\/000430867","article-title":"Mood stabilizers and the influence on global leukocyte DNA methylation in bipolar disorder","volume":"1","author":"Backlund","year":"2015","journal-title":"Mol. Neuropsychiatry"},{"key":"10.1016\/j.neulet.2016.06.045_bib0250","doi-asserted-by":"crossref","first-page":"210","DOI":"10.3109\/1547691X.2011.568979","article-title":"Valproic acid exhibits biphasic effects on apoptotic cell death of activated lymphocytes through differential modulation of multiple signaling pathways","volume":"8","author":"Chen","year":"2011","journal-title":"J. Immunotoxicol."},{"key":"10.1016\/j.neulet.2016.06.045_bib0255","doi-asserted-by":"crossref","first-page":"36734","DOI":"10.1074\/jbc.M101287200","article-title":"Histone deacetylase is a direct target of valproic acid, a potent anticonvulsant, mood stabilizer, and teratogen","volume":"276","author":"Phiel","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2016.06.045_bib0260","doi-asserted-by":"crossref","first-page":"27586","DOI":"10.1074\/jbc.M303740200","article-title":"Valproate induces replication-independent active DNA demethylation","volume":"278","author":"Detich","year":"2003","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2016.06.045_bib0265","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/carcin\/bgl167","article-title":"Valproate induces widespread epigenetic reprogramming which involves demethylation of specific genes","volume":"28","author":"Milutinovic","year":"2007","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.neulet.2016.06.045_bib0270","doi-asserted-by":"crossref","first-page":"35500","DOI":"10.1074\/jbc.M113.479865","article-title":"Lithium down-regulates histone deacetylase 1 (HDAC1) and induces degradation of mutant huntingtin","volume":"288","author":"Wu","year":"2013","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2016.06.045_bib0275","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jpba.2011.09.017","article-title":"Histone deacetylase 1 is required for carbamazepine-induced CYP3A4 expression","volume":"58","author":"Wu","year":"2012","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.neulet.2016.06.045_bib0280","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1017\/S1461145713000710","article-title":"Effect of mood stabilizers on DNA methylation in human neuroblastoma cells","volume":"16","author":"Asai","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neulet.2016.06.045_bib0285","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1523\/JNEUROSCI.0096-06.2006","article-title":"Endogenous alpha-synuclein is induced by valproic acid through histone deacetylase inhibition and participates in neuroprotection against glutamate-induced excitotoxicity","volume":"26","author":"Leng","year":"2006","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2016.06.045_bib0290","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.neures.2009.05.002","article-title":"Valproic acid induces up- or down-regulation of gene expression responsible for the neuronal excitation and inhibition in rat cortical neurons through its epigenetic actions","volume":"65","author":"Fukuchi","year":"2009","journal-title":"Neurosci. Res."},{"key":"10.1016\/j.neulet.2016.06.045_bib0295","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.neuropharm.2015.06.018","article-title":"Valproic acid exposure leads to upregulation and increased promoter histone acetylation of sepiapterin reductase in a serotonergic cell line","volume":"99","author":"Balasubramanian","year":"2015","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neulet.2016.06.045_bib0300","doi-asserted-by":"crossref","first-page":"e600","DOI":"10.1038\/tp.2015.90","article-title":"Search for common targets of lithium and valproic acid identifies novel epigenetic effects of lithium on the rat leptin receptor gene","volume":"5","author":"Lee","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neulet.2016.06.045_bib0305","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1038\/npp.2009.188","article-title":"Valproate and amitriptyline exert common and divergent influences on global and gene promoter-specific chromatin modifications in rat primary astrocytes","volume":"35","author":"Perisic","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2016.06.045_bib0310","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.brainres.2010.03.068","article-title":"Phospho-acetylation of histone H3 in the amygdala after acute lithium chloride","volume":"1333","author":"Kwon","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.neulet.2016.06.045_bib0315","doi-asserted-by":"crossref","first-page":"8455","DOI":"10.1073\/pnas.93.16.8455","article-title":"A molecular mechanism for the effect of lithium on development","volume":"93","author":"Klein","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neulet.2016.06.045_bib0320","doi-asserted-by":"crossref","first-page":"41337","DOI":"10.1074\/jbc.M110.170704","article-title":"Phosphatidylinositol 3-kinase (PI3K) signaling via glycogen synthase kinase-3 (Gsk-3) regulates DNA methylation of imprinted loci","volume":"285","author":"Popkie","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.neulet.2016.06.045_bib0325","doi-asserted-by":"crossref","first-page":"4189","DOI":"10.1007\/s00213-014-3565-7","article-title":"Lithium reduces the effects of rotenone-induced complex I dysfunction on DNA methylation and hydroxymethylation in rat cortical primary neurons","volume":"231","author":"Scola","year":"2014","journal-title":"Psychopharmacology (Berlin)"},{"key":"10.1016\/j.neulet.2016.06.045_bib0330","doi-asserted-by":"crossref","first-page":"e159","DOI":"10.1038\/tp.2012.86","article-title":"Upregulation of TET1 and downregulation of APOBEC3A and APOBEC3C in the parietal cortex of psychotic patients","volume":"2","author":"Dong","year":"2012","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neulet.2016.06.045_bib0335","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1017\/S1461145712000429","article-title":"Neuroprotective effects of the mood stabilizer lamotrigine against glutamate excitotoxicity: roles of chromatin remodelling and Bcl-2 induction","volume":"16","author":"Leng","year":"2013","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neulet.2016.06.045_bib0340","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/sj.tpj.6500269","article-title":"Valproic acid inhibits histone deacetylase activity and suppresses excitotoxicity-induced GAPDH nuclear accumulation and apoptotic death in neurons","volume":"4","author":"Kanai","year":"2004","journal-title":"Pharmacogenom. J."},{"key":"10.1016\/j.neulet.2016.06.045_bib0345","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.molbrainres.2004.10.021","article-title":"Valproate pretreatment protects dopaminergic neurons from LPS-induced neurotoxicity in rat primary midbrain cultures: role of microglia","volume":"134","author":"Peng","year":"2005","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neulet.2016.06.045_bib0350","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuroscience.2007.06.053","article-title":"Valproic acid and other histone deacetylase inhibitors induce microglial apoptosis and attenuate lipopolysaccharide-induced dopaminergic neurotoxicity","volume":"149","author":"Chen","year":"2007","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2016.06.045_bib0355","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.neuroscience.2012.06.012","article-title":"Valproic acid increases white matter repair and neurogenesis after stroke","volume":"220","author":"Liu","year":"2012","journal-title":"Neuroscience"},{"key":"10.1016\/j.neulet.2016.06.045_bib0360","first-page":"457","article-title":"Lithium-induced neuroprotection is associated with epigenetic modification of specific BDNF gene promoter and altered expression of apoptotic-regulatory proteins","volume":"8","author":"Dwivedi","year":"2014","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.neulet.2016.06.045_bib0365","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.nbd.2007.02.006","article-title":"Valproic acid-mediated neuroprotection in intracerebral hemorrhage via histone deacetylase inhibition and transcriptional activation","volume":"26","author":"Sinn","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neulet.2016.06.045_bib0370","doi-asserted-by":"crossref","first-page":"2576","DOI":"10.1523\/JNEUROSCI.5467-07.2008","article-title":"Synergistic neuroprotective effects of lithium and valproic acid or other histone deacetylase inhibitors in neurons: roles of glycogen synthase kinase-3 inhibition","volume":"28","author":"Leng","year":"2008","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neulet.2016.06.045_bib0375","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1590\/1516-4446-2013-1094","article-title":"Histone deacetylase activity and brain-derived neurotrophic factor (BDNF) levels in a pharmacological model of mania","volume":"36","author":"Stertz","year":"2014","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.neulet.2016.06.045_bib0380","doi-asserted-by":"crossref","first-page":"17095","DOI":"10.1073\/pnas.262658999","article-title":"An epigenetic mouse model for molecular and behavioral neuropathologies related to schizophrenia vulnerability","volume":"99","author":"Tremolizzo","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neulet.2016.06.045_bib0385","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/j.biopsych.2004.11.046","article-title":"Valproate corrects the schizophrenia-like epigenetic behavioral modifications induced by methionine in mice","volume":"57","author":"Tremolizzo","year":"2005","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.neulet.2016.06.045_bib0390","doi-asserted-by":"crossref","first-page":"4676","DOI":"10.1073\/pnas.0700529104","article-title":"Histone hyperacetylation induces demethylation of reelin and 67-kDa glutamic acid decarboxylase promoters","volume":"104","author":"Dong","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neulet.2016.06.045_bib0395","doi-asserted-by":"crossref","first-page":"13614","DOI":"10.1073\/pnas.0805493105","article-title":"Clozapine and sulpiride but not haloperidol or olanzapine activate brain DNA demethylation","volume":"105","author":"Dong","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neulet.2016.06.045_bib0400","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nrg2290","article-title":"Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?","volume":"9","author":"Filipowicz","year":"2008","journal-title":"Nat. Rev. Genet."},{"key":"10.1016\/j.neulet.2016.06.045_bib0405","doi-asserted-by":"crossref","first-page":"bau023","DOI":"10.1093\/database\/bau023","article-title":"EpimiR: a database of curated mutual regulation between miRNAs and epigenetic modifications","volume":"2014","author":"Dai","year":"2014","journal-title":"Database: J. Biol. Databases Curation"},{"key":"10.1016\/j.neulet.2016.06.045_bib0410","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cell.2004.12.035","article-title":"Conserved seed pairing often flanked by adenosines, indicates that thousands of human genes are microRNA targets","volume":"120","author":"Lewis","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.neulet.2016.06.045_bib0415","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s13105-010-0050-6","article-title":"Biological functions of microRNAs: a review","volume":"67","author":"Huang","year":"2011","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.neulet.2016.06.045_bib0420","doi-asserted-by":"crossref","first-page":"e678","DOI":"10.1038\/tp.2015.159","article-title":"Genome-wide analysis implicates microRNAs and their target genes in the development of bipolar disorder","volume":"5","author":"Forstner","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neulet.2016.06.045_bib0425","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1016\/j.jad.2016.04.021","article-title":"Peripheral whole blood microRNA alterations in major depression and bipolar disorder","volume":"200","author":"Maffioletti","year":"2016","journal-title":"J. Affect. Disord."},{"key":"10.1016\/j.neulet.2016.06.045_bib0430","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/npp.2008.131","article-title":"Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers","volume":"34","author":"Zhou","year":"2009","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.neulet.2016.06.045_bib0435","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1017\/S1461145709000029","article-title":"MicroRNA expression changes in lymphoblastoid cell lines in response to lithium treatment","volume":"12","author":"Chen","year":"2009","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.neulet.2016.06.045_bib0440","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jpsychires.2010.04.028","article-title":"MicroRNA-134 plasma levels before and after treatment for bipolar mania","volume":"45","author":"Rong","year":"2011","journal-title":"J. Psychiatr. Res."},{"key":"10.1016\/j.neulet.2016.06.045_bib0445","doi-asserted-by":"crossref","first-page":"e504","DOI":"10.1038\/tp.2014.139","article-title":"Novel integrative genomic tool for interrogating lithium response in bipolar disorder","volume":"5","author":"Hunsberger","year":"2015","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.neulet.2016.06.045_bib0450","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s12031-015-0523-8","article-title":"Insulin-like growth factor 1 differentially affects lithium sensitivity of lymphoblastoid cell lines from lithium responder and non-responder bipolar disorder patients","volume":"56","author":"Milanesi","year":"2015","journal-title":"J. Mol. Neurosci."},{"key":"10.1016\/j.neulet.2016.06.045_bib0455","doi-asserted-by":"crossref","first-page":"e82895","DOI":"10.1371\/journal.pone.0082895","article-title":"Valproic acid causes proteasomal degradation of DICER and influences miRNA expression","volume":"8","author":"Zhang","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neulet.2016.06.045_bib0460","doi-asserted-by":"crossref","first-page":"R43","DOI":"10.1186\/gb-2012-13-6-r43","article-title":"Functional annotation of the human brain methylome identifies tissue-specific epigenetic variation across brain and blood","volume":"13","author":"Davies","year":"2012","journal-title":"Genome Biol."}],"container-title":["Neuroscience Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394016304542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304394016304542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,22]],"date-time":"2020-09-22T21:11:24Z","timestamp":1600809084000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304394016304542"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":92,"alternative-id":["S0304394016304542"],"URL":"https:\/\/doi.org\/10.1016\/j.neulet.2016.06.045","relation":{},"ISSN":["0304-3940"],"issn-type":[{"value":"0304-3940","type":"print"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding the molecular mechanisms underlying mood stabilizer treatments in bipolar disorder: Potential involvement of epigenetics","name":"articletitle","label":"Article Title"},{"value":"Neuroscience Letters","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neulet.2016.06.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}